Laboratory of Molecular Biomedicine for Pathogenesis, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo 113-0033, Japan.
Nat Commun. 2013;4:1836. doi: 10.1038/ncomms2862.
Peptidylarginine deiminase 4 (PAD4) functions as a transcriptional coregulator by catalyzing the conversion of histone H3 arginine residues to citrulline residues. Although the high level of PAD4 expression in bone marrow cells suggests its involvement in haematopoiesis, its precise contribution remains unclear. Here we show that PAD4, which is highly expressed in lineage(-) Sca-1(+) c-Kit(+) (LSK) cells of mouse bone marrow compared with other progenitor cells, controls c-myc expression by catalyzing the citrullination of histone H3 on its promoter. Furthermore, PAD4 is associated with lymphoid enhancer-binding factor 1 and histone deacetylase 1 at the upstream region of the c-myc gene. Supporting these findings, LSK cells, especially multipotent progenitors, in PAD4-deficient mice show increased proliferation in a cell-autonomous fashion compared with those in wild-type mice. Together, our results strongly suggest that PAD4 regulates the proliferation of multipotent progenitors in the bone marrow by controlling c-myc expression.
肽基精氨酸脱亚氨酶 4(PAD4)通过催化组蛋白 H3 精氨酸残基转化为瓜氨酸残基,作为转录共调节剂发挥作用。尽管骨髓细胞中 PAD4 的高表达表明其参与造血过程,但确切的贡献仍不清楚。在这里,我们表明 PAD4 在小鼠骨髓的谱系(-)Sca-1(+)c-Kit(+)(LSK)细胞中高度表达,与其他祖细胞相比,通过催化其启动子上的组蛋白 H3 的瓜氨酸化来控制 c-myc 表达。此外,PAD4 与淋巴增强结合因子 1 和组蛋白去乙酰化酶 1 一起位于 c-myc 基因的上游区域。支持这些发现的是,与野生型小鼠相比,PAD4 缺陷小鼠的 LSK 细胞,特别是多能祖细胞,以细胞自主性方式表现出更高的增殖。总之,我们的结果强烈表明 PAD4 通过控制 c-myc 表达来调节骨髓中多能祖细胞的增殖。